Table 2.

Number of events and deaths for 1-year follow-up in the Danish population (all patients, patients on OAC, low-risk patients), GARFIELD-AF Global and GARFIELD-AF Scandinavia

	Danish AF cohort (n=90 693)	Patients treated with OAC (n=51 180)	Low-risk patients (n=20 673)	GARFIELD Scandinavia (n=2396)	GARFIELD-AF Global (n=52 080)
Ischaemic Stroke/SE	2094	994	139	24	599
Major bleeding/haemorrhagic stroke	2642	1492	242	28*	341†
Deaths	10 915	4521	623	88	2459

Low-risk patients were defined as CHA₂DS₂-VASc score (≤2 for women, 0–1 for men and >2 for women and >1 for men).

*Of those treated with OAC (n=1631)

†Of those treated with OAC (n=31 712)

AF, atrial fibrillation; GARFIELD-AF, Global Anticoagulant Registry in the FIELD-Atrial Fibrillation; OAC, oral anticoagulation; SE, systemic embolism.